• 제목/요약/키워드: Antitumor agents

검색결과 201건 처리시간 0.026초

한국산 생약으로부터 항암물질의 개발 (제9보). 비색분석법에 의한 포공령 추출물의 항암평가 (Development of Anticancer Agents from Korean Medicinal Plants. Part 9. Antitumor Evaluation of Taraxaci Herba Extracts by Colormetric Methods.)

  • 한두석;이명호;최규은;백승화
    • 한국환경성돌연변이발암원학회지
    • /
    • 제18권2호
    • /
    • pp.104-108
    • /
    • 1998
  • In the present study, we have evaluated cytotoxic effects of Taraxaci Herba extract in human oral epitheloid carcinoma cells. An antitumor activity was measured by colorimetric assays using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) and sulforhodamine protein B (SRB). The light microscopic study showed morphological changes, Ag-NOR (argyrophylic nucleolar organizer region) number and PAS positive reaction or the treated cells. These results obtained are as follows : MTT and SRB quantities were significantly decreased in cultured KB cells treated with 10$^{-2}$ /mg/ml and 10$^{-3}$ /mg/ml concentrations. The number of Ag-NORs were significantly decreased in cultured KB cells treated with 10$^{-2}$ /mg/ml and 10$^{-3}$ /mg/ml concentrations and the rate of Ag-NORs was shifted to left side (one Ag-Nounucleus was increased and five Ag-NORs/nucleus were decreased) by the high concentration. PAS reaction of cultured KB cells treated with 10$^{-2}$ /mg/ml and 10$^{-3}$ /mg/ml concentrations was negative. These results suggest that Taraxaci Herba retains a potential antitumor activity.

  • PDF

한국산 생약으로부터 항암물질의 개발 (제 5 보) - 소엽의 부탄올 가용분획이 인체피부흑색종 세포에 미치는 세포독성작용 - (Development of Anticancer Agents from Korean Medicinal Plants. Part 5 - Cytotoxic Activity of the Butanol Soluble Fraction of Perilla frutescens against Human Skin Melanoma Cells -)

  • 이기남;신혁호;한두석;김영옥;최규은;곽정숙;백승화
    • 생약학회지
    • /
    • 제28권4호
    • /
    • pp.264-270
    • /
    • 1997
  • This Study was carried out develop antitumor effect of the n-butanol soluble of fraction of Perilla frutescens on human skin melanoma cells. The antitumor activity of various fractions obtained form n-butanol soluble fraction of Perilla frutescens was evaluated in human skin melanoma cells. The antitumor activity of the n-butanol soluble fraction in human skin melanoma cells was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay, neutral red (NR) assay and sulforhordamine B protein (SRB) assay of colorimetic assay methods. The light microscopic study was carried out to observe morphological changes of cultured human skin melanoma cells. These results were obtained follows; The fractions 5 and 6 of the n-butanol soluble fraction of P frutescens were shown significant antitumor activities. The number of human skin melanoma cells were decreased and tend to form cell cluster by treatment with actions 5 and 7 of the n-butanol soluble fraction of P. frutescens. The fraction 6 of the the n-butanol soluble fraction showed the highest antitumor activity on P. frutescens. These results suggest that the fraction 6 of the n-butanol soluble fraction of P. frutescens may be a valuable choice for the studies on the treatment of human skin tumors.

  • PDF

Development of kNN QSAR Models for 3-Arylisoquinoline Antitumor Agents

  • Tropsha, Alexander;Golbraikh, Alexander;Cho, Won-Jea
    • Bulletin of the Korean Chemical Society
    • /
    • 제32권7호
    • /
    • pp.2397-2404
    • /
    • 2011
  • Variable selection k nearest neighbor QSAR modeling approach was applied to a data set of 80 3-arylisoquinolines exhibiting cytotoxicity against human lung tumor cell line (A-549). All compounds were characterized with molecular topology descriptors calculated with the MolconnZ program. Seven compounds were randomly selected from the original dataset and used as an external validation set. The remaining subset of 73 compounds was divided into multiple training (56 to 61 compounds) and test (17 to 12 compounds) sets using a chemical diversity sampling method developed in this group. Highly predictive models characterized by the leave-one out cross-validated $R^2$ ($q^2$) values greater than 0.8 for the training sets and $R^2$ values greater than 0.7 for the test sets have been obtained. The robustness of models was confirmed by the Y-randomization test: all models built using training sets with randomly shuffled activities were characterized by low $q^2{\leq}0.26$ and $R^2{\leq}0.22$ for training and test sets, respectively. Twelve best models (with the highest values of both $q^2$ and $R^2$) predicted the activities of the external validation set of seven compounds with $R^2$ ranging from 0.71 to 0.93.

한국산 도꼬마리 추출물로부터 항균.항암물질의 탐색 (Screening of the Antimicrobial and Antitumor Activity of Xanthium strumarium L.Extract)

  • 김현수;유대식;이인선;김용원;여수환
    • KSBB Journal
    • /
    • 제18권1호
    • /
    • pp.55-61
    • /
    • 2003
  • 항균 및 항암성 물질을 탐색하기 위하여 도꼬마리 열수 추출액을 ether 및 ethylacetate를 이용하여 중성, 산성, 염기성조건에서 추출한 후, 각각의 추출물을 세균 16균주 및 곰팡이와 효모 2균주를 대상으로 항균활성을 조사하였다. Ether 중성 추출물(XE-N)은 항균효과가 가장 우수하였으며, 특히 그람 양성세균(7균주), 그람 음성세균(7균주)을 비롯하여 진균중 Cryptococcus neoformans에도 뚜렷한 항균효과를 나타내었다. XE-N 및 XEA-N을 대상으로 FDA method에 의한 항균효과를 검토한 결과, p. aeruginosa를 제외한 3균주에 대해 30 ng/mL에서도 저해효과를 나타내었다 XE-N으로부터 XE-N-S1, XE-N-S3을, Ether 산성 추출물(XE-A)로부터 XE-N-S3 을, ethylacetate 중성 추출물(XEA-N)로부터 XEA-N-S2를 항균, 항암성 물질로 정제하였으나, XE-N-S1을 제외한 다른 물질들은 빠른 시간 내에 모두 분해되었다 도꼬마리 추출물 및 정제된 생리활성물질에 대한 항암효과를 검토한 결과, HeLa 자궁암 세포에 대해서는 XE-N-S1이 가장 우수하였다. HepG2간암세포에 대한 항암효과는 XE-N-S, XE-N-S3가 우수하였고, HT29 대장암세포에 대한 항암효과는 XE-N, XE-N-S1이 우수하였다. Saos2 골육종 암세포, NCI H522 폐선 암세포, NCI H1703 폐 편평세포 암세포와 Clone M3 흑색종 암세포에 대한 항암효과는 XE-N-S1이 가장 우수하였다. LN CAP 전립선 암세포에 대한 항암효과는 XE-N-S3가 가장 우수한 효과를 나타내었다. 또한 HSF 인간 정상 피부 섬유아세포에 대한 각종 추출물 및 정제물의 세포독성을 기존의 항암제인 etoposide와 cisplatin과 비교·검토한 결과, XE-A, XEA-A 및 XEA-B가 가장 독성이 낮았으며, XE-B도 etoposide에 비해 독성이 낮았다. 한편 XE-N-S1, XE-N-S3은 etoposide보다 높은 독성을 나타내었으며, XE-A-S3은 etoposide보다는 독성이 높았으나, cisplatin보다는 낮았다.

Synthesis of Benzo[c]phenanthridine Derivatives and their in Vitro Antitumor Activities

  • Cho, Won-Jea;Yoo, Su-Jeong;Chung, Byung-Ho;Choi, Bo-Gil;Cheon, Seung-Hoon;Whang, Soon-Ho;Kim, Sin-Kyu;Kang, Boo-Hyon;Lee, Chong-Ock
    • Archives of Pharmacal Research
    • /
    • 제19권4호
    • /
    • pp.321-325
    • /
    • 1996
  • Aiming at the development of anticancer agents by modification of phenolic benzo[c]phenanthridine alkaloid, additional hydroxyl group was put on C10 position of fagaridine (1) by a biomimetic synthetic procedure to afford 10-hydroxyfagaridine (12). All of the synthetic intermediates were also screened in vitro antitumor activities against five different cell lines as well as 12. Among them the representative cytotoxic results are shown as follows; P-quinone (11) $[ED_50;(A549=0.22; {\mu}g/ml)$, $(HCT;15=0.21 {\mu}g/ml)$, fagaridine (1) $(HCT;15=0.41 {\mu}g/ml)$, olefin (6) $(HCT; 15=0.06 {\mu}g/ml)$, acetal (7) $(SKMEL-2=0.07 {\mu}g/ml)$, dihydrofagaridne (10) $(A549=0.38 {\mu}g/ml)$, 10-hydroxyfagaridine (12) $(A 549=0.45{\mu}g/mi)$. From these observation three main remarks can be drawn; (i) the iminium part of benzo[c]phenanthridine is not essential for showing acitvities, (ii) the additional hydroxyl group did not contribute to enhance the cytotoxicity, (iii) the 3-arylisoquinolin-1(2H)-one derivatives were found to display significant in vitro antitumor activity.

  • PDF

Cytotoxic and Apoptotic Activites of Echinomycin Derivative (Echinomycin-7) on P388 Murine Leukemia Cells

  • Jeon, Hyang;Kim, Sung-Su;Kim, Yoon-Suk;Park, Yil-Sung;Kim, Yong-Hae;Choi, Sun-Ju;Kim, Soo-Kie;Kim, Tae-Ue
    • BMB Reports
    • /
    • 제31권6호
    • /
    • pp.560-564
    • /
    • 1998
  • Echinomycin-7 is an echinomycin derivative, Smethylated sulfonium perchlorate of echinomycin. We studied the in vitro cytotoxicity and in vivo antitumor activity of echinomycin-7 against P388 leukemia cells and compared the results with echinomycin. With respect to the cytotoxic effects, echinomycin-7 had cell line-dependent $IC_{50}$ values while echinomycin had similar values to several tumor cell lines. Also, in vivo antitumor activities were observed in tumor-bearing mice treated with both agents, which showed that echinomycin-7 had a broad therapeutic dose range. We also observed the apoptosis on leukemia cells treated with echinomycin-7 which exihibited the ladder pattern of DNA on electrophoresis. In addition to apoptosis, echinomycin-7 arrested $G_1/S$ phases of the cell cycle at the same time. We then examined the signaling pathway of echinomycin-7-induced apoptosis and showed that ERK of the MAP kinase family was activated and translocated into the nucleus by echinomycin-7 stimulation. This study suggests that echinomycin-7 acts as an antitumor agent through in vitro cytotoxicity and has in vivo antitumor activity against leukemia cells, and that the echinomycin-7- induced apoptosis might involve signal transduction via MAP kinases.

  • PDF